发明申请
US20120064089A1 ANTI-CXCL16 AND ANTI-CXCR6 ANTIBODIES FOR THE PREVENTION AND TREATMENT OF CANCER AND CANCER CELL MIGRATION
审中-公开
抗CXCL16和抗CXCR6预防和治疗癌症和癌细胞迁移的抗体
- 专利标题： ANTI-CXCL16 AND ANTI-CXCR6 ANTIBODIES FOR THE PREVENTION AND TREATMENT OF CANCER AND CANCER CELL MIGRATION
- 专利标题（中）： 抗CXCL16和抗CXCR6预防和治疗癌症和癌细胞迁移的抗体
-
申请号： US13233769申请日： 2011-09-15
-
公开(公告)号： US20120064089A1公开(公告)日： 2012-03-15
- 发明人: James W. Lillard , Rajesh Singh , Shailesh Singh
- 申请人： James W. Lillard , Rajesh Singh , Shailesh Singh
- 申请人地址： US GA Atlanta
- 专利权人： Morehouse School of Medicine
- 当前专利权人： Morehouse School of Medicine
- 当前专利权人地址： US GA Atlanta
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; A61K39/00 ; A61P37/04 ; A61P35/04 ; A61P35/02 ; A61K31/7088 ; A61P35/00
摘要：
Methods for prevention or inhibition of the growth or metastasis of cancer cells in a subject are disclosed. One method comprises the step of administering to the subject a therapeutically effective amount of an antibody to the chemokine CXCL16 and/or the chemokine receptor CXCR6. Another method comprises the step of administering to the subject a therapeutically effective amount of an expression vector that expresses an antibody to the chemokine CXCL16 and/or the chemokine receptor CXCR6.
信息查询
